Novo-Selegiline en es it fr

Novo-Selegiline Brand names, Novo-Selegiline Analogs

Novo-Selegiline Brand Names Mixture

  • No information avaliable

Novo-Selegiline Chemical_Formula


Novo-Selegiline RX_link

Novo-Selegiline fda sheet

Novo-Selegiline FDA

Novo-Selegiline msds (material safety sheet)

Novo-Selegiline MSDS

Novo-Selegiline Synthesis Reference

Torok Z et al., Acta Pharm Hung. 1992 Sep;62(5):201-11

Novo-Selegiline Molecular Weight

187.281 g/mol

Novo-Selegiline Melting Point

141-142 oC

Novo-Selegiline H2O Solubility

No information avaliable

Novo-Selegiline State


Novo-Selegiline LogP


Novo-Selegiline Dosage Forms


Novo-Selegiline Indication

For the adjunct treatment for Parkinson's disease.

Novo-Selegiline Pharmacology

Dopamine is an essential chemical that occurs in many parts of the body. It is the premature degradation of dopamine that results in the symptoms of Parkinson's disease. Monoamine oxidase (MAO) is an enzyme which accelerates the breakdown of dopamine. Selegiline can prolong the effects of dopamine in the brain by preventing its breakdown through seletively blocking MAO. It also may prevent the removal of dopamine between nerve endings and enhance release of dopamine from nerve cells.

Novo-Selegiline Absorption

Rapidly absorbed from the gastrointestinal tract.

Novo-Selegiline side effects and Toxicity

LD50=63 mg/kg (rats, IV)

Novo-Selegiline Patient Information

Novo-Selegiline Organisms Affected

Humans and other mammals